TickerGuard
Buy Day today: Poor (58) Mixed market breadth · today: CPI (July)
ATR

AptarGroup Inc

Healthcare · Medical Instruments & Supplies

134.80$ +0.8% vs. previous close Closing price · As of: Aug 11, 2026

Statements

Segments

US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of AptarGroup Inc (ATR). It shows which part of the business is growing — and which one is holding it back.

Revenue by business segment

Revenue by business segment — ATR
Segment 2020 2021 2022 2023 2024 2025
Pharma $1.52B 43.6% $1.64B 45.9% · +8.0% $1.74B 46.0% · +5.7%
Beauty $1.27B 36.4% $1.23B 34.2% · -3.3% $1.31B 34.7% · +6.8%
Closures $698.8M 20.0% $714.0M 19.9% · +2.2% $730.3M 19.3% · +2.3%
Pharma $1.23B 41.8%
Beauty + Home $1.30B 44.3%
Food + Beverage $405.4M 13.8%
Aptar Pharma $1.28B 39.8% $1.36B 41.0% · +6.0%
Aptar Beauty $1.18B 36.6% $1.22B 36.8% · +3.4%
Aptar Closures $760.8M 23.6% $738.5M 22.2% · -2.9%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.

Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?